📣 VC round data is live. Check it out!

Cofoe Medical Valuation Multiples

Discover Cofoe Medical's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like PROCEPT BioRobotics, Nakanishi, Immunocore Holdings, Weigao Group and more.

Cofoe Medical Overview

About Cofoe Medical

Cofoe Medical Technology Co Ltd is engaged in the research and development, production, sales and service of home medical equipment.


Founded

2009

HQ

China

Employees

N/A

Financials (LTM)

Revenue: $544M
EBITDA: $98M

EV

$1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Cofoe Medical Financials

Cofoe Medical reported last 12-month revenue of $544M and EBITDA of $98M.

In the same LTM period, Cofoe Medical generated $293M in gross profit, $98M in EBITDA, and $60M in net income.

Revenue (LTM)


Cofoe Medical P&L

In the most recent fiscal year, Cofoe Medical reported revenue of $501M and EBITDA of $93M.

Cofoe Medical is profitable as of last fiscal year, with gross margin of 53%, EBITDA margin of 18%, and net margin of 11%.

See analyst estimates for Cofoe Medical
LTMLast FY202320242025202620272028
Revenue$544M$501M$422M$441M$501M
Gross Profit$293M$266M$183M$229M$266M
Gross Margin54%53%43%52%53%
EBITDA$98M$93M$64M$82M$93M
EBITDA Margin18%18%15%18%18%
EBIT Margin13%12%10%12%12%
Net Profit$60M$55M$38M$46M$55M
Net Margin11%11%9%10%11%

Financial data powered by Morningstar, Inc.

Cofoe Medical Stock Performance

Cofoe Medical has current market cap of $2B, and enterprise value of $1B.

Market Cap Evolution


Cofoe Medical's stock price is $6.47.

Cofoe Medical share price decreased by 1.5% in the last 30 days, and increased by 34.2% in the last year.

Cofoe Medical has an EPS (earnings per share) of $0.23.

See more trading valuation data for Cofoe Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1B$2B-1.8%-1.5%-21.5%34.2%$0.23

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Cofoe Medical Valuation Multiples

Cofoe Medical trades at 2.4x EV/Revenue multiple, and 13.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Cofoe Medical

EV / Revenue (LTM)


Cofoe Medical Financial Valuation Multiples

As of June 3, 2026, Cofoe Medical has market cap of $2B and EV of $1B.

Cofoe Medical has a P/E ratio of 25.3x.

LTMLast FY202320242025202620272028
EV/Revenue2.4x2.6x3.0x2.9x2.6x
EV/EBITDA13.1x13.9x19.9x15.7x13.9x
EV/EBIT18.4x20.5x31.2x24.0x21.9x
EV/Gross Profit4.4x4.8x7.0x5.6x4.8x
P/E25.3x27.8x40.6x33.1x27.8x
EV/FCF-16.8xn/m16.0x16.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Cofoe Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Cofoe Medical Margins & Growth Rates

Cofoe Medical grew revenue by 23% and EBITDA by 25% in the last fiscal year.

In the most recent fiscal year, Cofoe Medical reported gross margin of 53%, EBITDA margin of 18%, and net margin of 11%.

See estimated margins and future growth rates for Cofoe Medical

Cofoe Medical Margins

Last FY202420252026202720282029
Gross Margin53%52%53%55%
EBITDA Margin18%18%18%19%
EBIT Margin12%12%12%13%
Net Margin11%10%11%11%
FCF Margin15%18%15%-

Cofoe Medical Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth23%5%14%23%
Gross Profit Growth26%25%16%26%
EBITDA Growth25%27%13%25%
EBIT Growth28%30%9%36%
Net Profit Growth25%23%19%25%
FCF Growth-2536%(5%)-

Data powered by FactSet, Inc. and Morningstar, Inc.

Cofoe Medical Operational KPIs

Cofoe Medical's Rule of 40 is 41% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Cofoe Medical's Rule of X is 75% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Cofoe Medical
LTMLast FY202320242025202620272028
Rule of 4042%41%---
Bessemer Rule of X77%75%---
S&M Expenses to Revenue34%34%14%18%21%
G&A Expenses to Revenue5%5%1%1%2%
R&D Expenses to Revenue3%3%4%3%3%
Opex to Revenue-41%34%40%41%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Cofoe Medical Competitors

Cofoe Medical competitors include PROCEPT BioRobotics, Nakanishi, Immunocore Holdings, Weigao Group, El.En. Group, BoneSupport, Savaria, Haier Biomedical, SKAN Group and Qingdao Baheal Medical.

Most Cofoe Medical public comparables operate across Medical Devices, HealthTech and DeepTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
PROCEPT BioRobotics4.4x3.9x(27.0x)(34.2x)
Nakanishi2.5x2.4x10.3x9.9x
Immunocore Holdings2.7x2.6x(298.4x)(47.1x)
Weigao Group5.6x5.3x16.1x16.6x
El.En. Group1.8x1.8x11.9x11.4x
BoneSupport11.9x10.7x57.4x44.0x
Savaria2.4x2.3x11.6x11.2x
Haier Biomedical3.6x3.5x21.3x21.2x

This data is available for Pro users. Sign up to see all Cofoe Medical competitors and their valuation data.

Start Free Trial

Cofoe Medical VC Funding History

Before going public, Cofoe Medical raised $4M in total equity funding, across 3 rounds.


Cofoe Medical Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Jul-19SeedBofu Fund Management; Dingxin Taihe; Fortune Venture Capital; Redhill Capital; Yanjin Puzi$2M--
Jan-19Series ADingxin Taihe$2M--
Oct-17AngelHuaige Capital$500K--

Acquisitions by Cofoe Medical

Cofoe Medical has acquired 3 companies to date.

Last acquisition by Cofoe Medical was on December 27th 2022. Cofoe Medical acquired Laihe Biotech for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Cofoe Medical

Laihe Biotech
Acorn International
Jirui Medical
Description
Laihe Biotech is a Hangzhou-based biotechnology company advancing point-of-care testing (POCT) devices for real-time diagnostics of infectious diseases and chronic conditions. Its Lyher.com platform commercializes fluorescence immunoassay analyzers and test kits for COVID-19, cardiac markers, and tumor biomarkers. The firm operates a 10,000-square-meter R&D and manufacturing facility compliant with GMP standards. Founded in 2010, Laihe Biotech supplies systems to hospitals and clinics across Asia and exports to Southeast Asia.
Acorn International is a Shanghai-based marketing company operating in China's digital media landscape, with divisions in product sales, content distribution, and influencer management. The Product Division sells consumer goods via Tmall and JD.com platforms alongside offline channels. Acorn Streaming in the Content Division produces live and video-on-demand for platforms like Douyin. The Influencer Division represents U.S. celebrities for Weibo and Xiaohongshu presence. Publicly listed on NYSE until 2022, it leverages 20 years of direct marketing expertise.
Jirui Medical is a high-tech manufacturer of electric wheelchairs, scooters, and rehabilitation equipment in China. The company integrates R&D, production, and sales to supply mobility solutions for medical and daily use.
HQ CountryChinaChinaChina
HQ City
Hangzhou
Shanghai
Shanghai
Deal Date27 Dec 20223 Mar 20228 Nov 2021
Valuationundisclosedundisclosed$8M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Cofoe Medical acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Cofoe Medical

Cofoe Medical has invested in 1 company to date.

Latest investment by Cofoe Medical was on December 25th 2025. Cofoe Medical invested in Resvent in their Series B round.

See VC round multiples

Latest Investments by Cofoe Medical

Resvent
Description
Resvent is a Shenzhen-headquartered medical device company founded in 2015, focusing on respiration and ventilation solutions including sleep therapy, critical care ventilators, and cloud-based systems.
HQ CountryChina
HQ City
-
Deal Date25 Dec 2025
RoundSeries B
Raisedundisclosed
InvestorsCofoe Medical
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Cofoe Medical investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Cofoe Medical

When was Cofoe Medical founded?Cofoe Medical was founded in 2009.
Where is Cofoe Medical headquartered?Cofoe Medical is headquartered in China.
Is Cofoe Medical publicly listed?Yes, Cofoe Medical is a public company listed on Shenzhen Stock Exchange.
What is the stock symbol of Cofoe Medical?Cofoe Medical trades under 301087 ticker.
When did Cofoe Medical go public?Cofoe Medical went public in 2021.
Who are competitors of Cofoe Medical?Cofoe Medical main competitors include PROCEPT BioRobotics, Nakanishi, Immunocore Holdings, Weigao Group, El.En. Group, BoneSupport, Savaria, Haier Biomedical, SKAN Group, Qingdao Baheal Medical.
What is the current market cap of Cofoe Medical?Cofoe Medical's current market cap is $2B.
What is the current revenue of Cofoe Medical?Cofoe Medical's last 12 months revenue is $544M.
What is the current revenue growth of Cofoe Medical?Cofoe Medical revenue growth (NTM/LTM) is 24%.
What is the current EV/Revenue multiple of Cofoe Medical?Current revenue multiple of Cofoe Medical is 2.4x.
What is the current EBITDA of Cofoe Medical?Cofoe Medical's last 12 months EBITDA is $98M.
What is Cofoe Medical's EBITDA margin?Cofoe Medical's last 12 months EBITDA margin is 18%.
What is the current EV/EBITDA multiple of Cofoe Medical?Current EBITDA multiple of Cofoe Medical is 13.1x.
How many companies Cofoe Medical has acquired to date?As of June 2026, Cofoe Medical has acquired 3 companies.
What was the largest acquisition by Cofoe Medical?$8M acquisition of Jirui Medical on 8th November 2021 was the largest M&A Cofoe Medical has done to date.
What companies Cofoe Medical acquired?Cofoe Medical acquired Jirui Medical, Laihe Biotech, and Acorn International.
In how many companies Cofoe Medical has invested to date?As of June 2026, Cofoe Medical has invested in 1 company.
What was the last Cofoe Medical investment?On 25th December 2025 Cofoe Medical invested in Resvent, participating in a Series B round.
In what companies Cofoe Medical invested in?Cofoe Medical invested in Resvent.

See public comps similar to Cofoe Medical

Lists including Cofoe Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial